Left Atrial Appendage Thrombus Prior to Ventricular Tachycardia Ablation: Is Combined Treatment a Viable Option?

Area of Science:

• Cardiology
• Electrophysiology
• Cardiovascular Interventions

Background:

• Catheter-based ventricular tachycardia (VT) ablation is a primary treatment for VT in structural heart disease.
• Intraventricular thrombus, often linked to ventricular aneurysms, is a key contraindication for VT ablation.
• Atrial thrombus in patients with atrial fibrillation undergoing VT ablation poses a significant embolic risk.

Observation:

• Detection of atrial thrombus typically leads to VT ablation cancellation, delaying treatment and increasing recurrent VT risk.
• A combined strategy may overcome the contraindication posed by atrial thrombus.
• Percutaneous left atrial appendage closure followed by VT ablation is explored as a potential solution.

Findings:

• A combined percutaneous left atrial appendage closure and VT ablation strategy may allow safe and effective treatment for patients with both atrial thrombus and VT.
• This approach addresses the contraindication of atrial thrombus, enabling timely VT ablation.
• It potentially mitigates the risk of embolic events associated with catheter manipulation during VT ablation.

Implications:

• This combined strategy could expand treatment options for patients with complex cardiac conditions, including VT and atrial fibrillation with thrombus.
• It offers a pathway to manage both conditions concurrently, improving patient outcomes and reducing treatment delays.
• Further research into the safety and efficacy of this combined approach is warranted for broader clinical adoption.